Net profit of Natco Pharma declined 34.11% to Rs 267.90 crore in the quarter ended March 2026 as against Rs 406.60 crore during the previous quarter ended March 2025. Sales declined 39.47% to Rs 739.10 crore in the quarter ended March 2026 as against Rs 1221.00 crore during the previous quarter ended March 2025.
For the full year,net profit declined 24.76% to Rs 1418.50 crore in the year ended March 2026 as against Rs 1885.40 crore during the previous year ended March 2025. Sales declined 7.93% to Rs 4078.30 crore in the year ended March 2026 as against Rs 4429.50 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 739.10 | 1221.00 | -39 | 4078.30 | 4429.50 | -8 |
| OPM % | 17.26 | 44.89 | - | 35.22 | 49.58 | - |
| PBDT | 194.50 | 604.20 | -68 | 1697.40 | 2526.60 | -33 |
| PBT | 144.10 | 505.90 | -72 | 1490.80 | 2291.40 | -35 |
| NP | 267.90 | 406.60 | -34 | 1418.50 | 1885.40 | -25 |
Powered by Capital Market - Live News